Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA

Citation
N. Ikeda et al., Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA, JPN J CANC, 91(9), 2000, pp. 918-924
Citations number
15
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
JAPANESE JOURNAL OF CANCER RESEARCH
ISSN journal
09105050 → ACNP
Volume
91
Issue
9
Year of publication
2000
Pages
918 - 924
Database
ISI
SICI code
0910-5050(200009)91:9<918:PSOOBM>2.0.ZU;2-9
Abstract
Amplification of cytokeratin 19 (CK19) transcripts by reverse transcriptase -polymerase chain reaction (RT-PCR) has been shown to be a highly sensitive assay for the detection of hone marrow micrometastases (BMM) of breast can cer, but recent studies have demonstrated the occurrence of false-positive results due to low-level, illegitimately transcribed CK19 in normal bone ma rrow tissue. One approach to solve this problem is to develop a quantitativ e CK19 RT-PCR assay and to introduce a cut-off value which can distinguish between illegitimate expression and cancer-specific expression levels, In t he present paper, we describe a quantitative CK19 RT-PCR assay using a real -time automated PCR system, The number of CK19 transcripts was normalized t o that of GAPDH transcripts as an internal control for quality and quantity of cDNA. The cut-off value for the ratio of CK19 to GAPDH transcripts was set at 10(-4) since the ratio never exceeded this value in the control bone marrow samples (n=12), In total, 117 bone marrow aspirates from stage I-II I patients with invasive breast cancers were subjected to CK19 RT-PCR assay and immunocytological examination. Forty (34.2%) were found to be BMM-posi tive by CK19 KT-PCR assay whereas only three (2.6%) were found to be BMM-po sitive by immunocytology, Multivariate analysis has shown that occult BMM d etected by CK19 RT-PCR is a significant risk factor for relapse, being inde pendent of axillary lymph node metastases.